Skip to main content
. 2021 Mar 9;9:644667. doi: 10.3389/fcell.2021.644667

FIGURE 3.

FIGURE 3

Activation of AMPK improved the metabolic maturation of hiPSC-CMs. (A) Western blot analysis of AMPK and phospho-AMPK expression in hiPSC-CMs treated with AICAR at various concentrations (0, 0.1, 0.5, and 1 mM). AICAR (0.5 and 1 mM) effectively upregulated the expression of phospho-AMPK (n = 3). (B) CCK-8 assay was performed to assess viability of hiPSC-CMs treated with AICAR at various concentrations (n = 3). **P < 0.01, ***P < 0.001, ****P < 0.0001 one-way ANOVA. (C) Western blot analysis of the effect of AMPK activation by AICAR on the protein expression levels of AMPK, p-AMPK, PGC-1α, PPARα, and ERRα (n = 3). (D) RT-qPCR analysis of the effect of AMPK activation by AICAR on the mRNA expression levels of PGC-1α, PPARα, and ERRα (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001 compared with the control group, unpaired t-test.